BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25405571)

  • 1. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
    Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
    Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone.
    Mirkin S; Graham S; Revicki DA; Bender RH; Bernick B; Constantine GD
    Menopause; 2019 Jan; 26(6):637-642. PubMed ID: 30601452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
    Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
    Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.
    Diem SJ; Guthrie KA; Mitchell CM; Reed SD; Larson JC; Ensrud KE; LaCroix AZ
    Menopause; 2018 Oct; 25(10):1086-1093. PubMed ID: 29738424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial.
    LaCroix AZ; Freeman EW; Larson J; Carpenter JS; Joffe H; Reed SD; Newton KM; Seguin RA; Sternfeld B; Cohen L; Ensrud KE
    Maturitas; 2012 Dec; 73(4):361-8. PubMed ID: 23031421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
    Ensrud KE; Guthrie KA; Hohensee C; Caan B; Carpenter JS; Freeman EW; LaCroix AZ; Landis CA; Manson J; Newton KM; Otte J; Reed SD; Shifren JL; Sternfeld B; Woods NF; Joffe H
    Sleep; 2015 Jan; 38(1):97-108. PubMed ID: 25325454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
    Guthrie KA; LaCroix AZ; Ensrud KE; Joffe H; Newton KM; Reed SD; Caan B; Carpenter JS; Cohen LS; Freeman EW; Larson JC; Manson JE; Rexrode K; Skaar TC; Sternfeld B; Anderson GL
    Obstet Gynecol; 2015 Aug; 126(2):413-422. PubMed ID: 26241433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.
    Reed SD; Mitchell CM; Joffe H; Cohen L; Shifren JL; Newton KM; Freeman EW; Larson JC; Manson JE; LaCroix AZ; Guthrie KA
    Obstet Gynecol; 2014 Aug; 124(2 Pt 1):233-241. PubMed ID: 25004335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants decrease hot flashes and improve life quality.
    Ruddy KJ; Loprinzi CL
    Menopause; 2015 Jun; 22(6):587-8. PubMed ID: 25756695
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
    Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
    Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms.
    Constantine GD; Revicki DA; Kagan R; Simon JA; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):513-519. PubMed ID: 30516713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.
    Kaunitz AM; Bitner D; Constantine GD; Bernick B; Graham S; Mirkin S
    Menopause; 2020 Dec; 27(12):1382-1387. PubMed ID: 32740481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.
    Cohen LS; Joffe H; Guthrie KA; Ensrud KE; Freeman M; Carpenter JS; Learman LA; Newton KM; Reed SD; Manson JE; Sternfeld B; Caan B; Freeman EW; LaCroix AZ; Tinker LF; Booth-Laforce C; Larson JC; Anderson GL
    Menopause; 2014 Apr; 21(4):347-54. PubMed ID: 23982113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
    Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
    JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial.
    Ensrud KE; Joffe H; Guthrie KA; Larson JC; Reed SD; Newton KM; Sternfeld B; Lacroix AZ; Landis CA; Woods NF; Freeman EW
    Menopause; 2012 Aug; 19(8):848-55. PubMed ID: 22433978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.